PDB16 COST-EFFECTIVENESS OF BLOOD PRESSURE AND URINARY ALBUMIN CONTROL IN DIABETICS WITH AN ANGIOTENSIN II RECEPTOR ANTAGONIST AND A CALCIUM CHANNEL BLOCKER: PHARMACOECONOMIC ANALYSIS OF THE MARVAL TRIAL-THE CASE OF GERMANY

Cost-effectiveness of renoprotection in diabetic patients with an angiotensin II receptor antagonist and a calcium channel blocker: economic analysis of the marval trial

American Journal of Hypertension ◽

10.1016/s0895-7061(03)00337-6 ◽

2003 ◽

Vol 16 (5) ◽

pp. A101

Author(s):

D SMITH

Keyword(s):

Cost Effectiveness ◽

Angiotensin Ii ◽

Economic Analysis ◽

Calcium Channel ◽

Receptor Antagonist ◽

Calcium Channel Blocker ◽

Channel Blocker ◽

Diabetic Patients ◽

Angiotensin Ii Receptor ◽

Combination of Angiotensin II Receptor Antagonist with Calcium Channel Blocker or Diuretic as Antihypertensive Therapy for Patients with Chronic Kidney Disease

Clinical and Experimental Hypertension ◽

10.3109/10641963.2010.503299 ◽

2011 ◽

Vol 33 (6) ◽

pp. 366-372 ◽

Cited By ~ 8

Author(s):

Toshihiko Ishimitsu ◽

Eri Ohno ◽

Nobuyuki Nakano ◽

Satoshi Furukata ◽

Akira Akashiba ◽

...

Keyword(s):

Chronic Kidney Disease ◽

Angiotensin Ii ◽

Kidney Disease ◽

Calcium Channel ◽

Receptor Antagonist ◽

Calcium Channel Blocker ◽

Antihypertensive Therapy ◽

Channel Blocker ◽

Angiotensin Ii Receptor ◽

PS 14-47 COMBINED ANTIHYPERTENSIVE THERAPY WITH ANGIOTENSIN II RECEPTOR ANTAGONIST AND CALCIUM CHANNEL BLOCKER IN PATIENTS WITH METABOLIC SYNDROME

10.1097/01.hjh.0000501169.72163.98 ◽

2016 ◽

Vol 34 (Supplement 1) ◽

pp. e447

Author(s):

Jamol Uzokov ◽

Anis Alyavi ◽

Sarvar Hojiev ◽

Davron Yaxshilikov ◽

Sarvar Dadaev

Keyword(s):

Metabolic Syndrome ◽

Angiotensin Ii ◽

Calcium Channel ◽

Receptor Antagonist ◽

Calcium Channel Blocker ◽

Antihypertensive Therapy ◽

Channel Blocker ◽

Angiotensin Ii Receptor ◽

Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study

Clinical and Experimental Nephrology ◽

10.1007/s10157-003-0241-3 ◽

2003 ◽

Vol 7 (3) ◽

pp. 221-230 ◽

Cited By ~ 13

Author(s):

Yasuhiko Iino ◽

Matsuhiko Hayashi ◽

Tetsuya Kawamura ◽

Tatsuo Shiigai ◽

Yasuhiko Tomino ◽

...

Keyword(s):

Chronic Kidney Disease ◽

Angiotensin Ii ◽

Kidney Disease ◽

Calcium Channel ◽

Receptor Antagonist ◽

Channel Blocker ◽

Angiotensin Ii Receptor ◽

Renal Protection ◽

COMBINED EFFECTS OF ANGIOTENSIN II RECEPTOR ANTAGONIST AND CALCIUM CHANNEL BLOCKER IN HYPERTENSIVE PATIENTS WITH TYPE 2 DIABETES: PP.17.160

10.1097/01.hjh.0000379086.40169.10 ◽

2010 ◽

Vol 28 ◽

pp. e297-e298

Author(s):

T Yokoi ◽

S Nakade ◽

H Masaki ◽

Y Komiyama ◽

M Masuda ◽

...

Keyword(s):

Type 2 Diabetes ◽

Angiotensin Ii ◽

Calcium Channel ◽

Receptor Antagonist ◽

Channel Blocker ◽

Combined Effects ◽

Angiotensin Ii Receptor ◽

Equivalent blood pressure reduction with angiotensin ii receptor antagonist based therapy compared with a calcium channel blocker in mild-to-moderate hypertensive patients of african origin

American Journal of Hypertension ◽

10.1016/j.amjhyper.2004.03.303 ◽

2004 ◽

Vol 17 (5) ◽

pp. S116

Author(s):

E LIBHABER

Keyword(s):

Blood Pressure ◽

Angiotensin Ii ◽

Receptor Antagonist ◽

Channel Blocker ◽

Blood Pressure Reduction ◽

Pressure Reduction ◽

African Origin ◽

Angiotensin Ii Receptor ◽

COMBINED EFFECTS OF CALCIUM CHANNEL BLOCKER AND ANGIOTENSIN II RECEPTOR ANTAGONIST IN HYPERTENSIVE PATIENTS WITH TYPE 2 DIABETES

10.1097/00004872-201106001-00656 ◽

2011 ◽

Vol 29 ◽

pp. e236

Author(s):

T. Yokoi ◽

S. Nakade ◽

H. Masaki ◽

H. Takahashi

Keyword(s):

Type 2 Diabetes ◽

Angiotensin Ii ◽

Calcium Channel ◽

Receptor Antagonist ◽

Channel Blocker ◽

Combined Effects ◽

Angiotensin Ii Receptor ◽

Angiotensin-II receptor antagonist combined with calcium channel blocker or diuretic for essential hypertension

Hypertension Research ◽

10.1038/hr.2009.133 ◽

2009 ◽

Vol 32 (11) ◽

pp. 962-968 ◽

Cited By ~ 41

Author(s):

Toshihiko Ishimitsu ◽

Atsushi Numabe ◽

Toshihide Masuda ◽

Tomoyuki Akabane ◽

Atsushi Okamura ◽

...

Keyword(s):

Essential Hypertension ◽

Angiotensin Ii ◽

Calcium Channel ◽

Receptor Antagonist ◽

Calcium Channel Blocker ◽

Channel Blocker ◽

Angiotensin Ii Receptor ◽

940 COMBINED EFFECTS OF ANGIOTENSIN II RECEPTOR ANTAGONIST AND CALCIUM CHANNEL BLOCKER IN HYPERTENSIVE PATIENTS WITH TYPE 2 DIABETES-

10.1097/01.hjh.0000420851.56988.3d ◽

2012 ◽

Vol 30 ◽

pp. e271

Author(s):

Toyohiko Yokoi ◽

Junya Azuma ◽

Yukiyoshi Nakade ◽

Fumihiro Sanada ◽

Kazuma Iekushi ◽

...

Keyword(s):

Type 2 Diabetes ◽

Angiotensin Ii ◽

Calcium Channel ◽

Receptor Antagonist ◽

Channel Blocker ◽

Combined Effects ◽

Angiotensin Ii Receptor ◽

Influence of the angiotensin II receptor antagonist losartan on diuretic-induced metabolic effects in elderly hypertensive patients: comparison with a calcium channel blocker

International Journal of Clinical Pharmacology and Therapeutics ◽

10.5414/cpp39417 ◽

2009 ◽

Author(s):

K. Ohnishi ◽

M. Kohno ◽

K. Yukiiri ◽

H. Masugata ◽

Y. Wada ◽

...

Keyword(s):

Angiotensin Ii ◽

Calcium Channel ◽

Receptor Antagonist ◽

Channel Blocker ◽

Metabolic Effects ◽

Angiotensin Ii Receptor ◽

Hypertensive Patients ◽

Elderly Hypertensive ◽

Elderly Hypertensive Patients